Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: Effect of maternal zidovudine treatment on viral load

JAMA

Volumn 275, Issue 8, 1996, Pages 599-605

  Dickover, Ruth E ^a   Garratty, Eileen M ^a   Herman, Steven A ^b   Sim, Myung Shin ^a   Plaeger, Susan ^a   Boyer, Pamela J ^a   Keller, Margaret ^c   Deveikis, Audra ^d   Stiehm, E Richard ^a   Bryson, Yvonne J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HYPERIMMUNE GLOBULIN; PLACEBO; VIRUS RNA; ZIDOVUDINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESISTANCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MATERNAL DISEASE; NEWBORN; ORAL DRUG ADMINISTRATION; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VIRUS CONCENTRATION;

EID: 13344293705     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.8.599     Document Type: Article

References (29)

1. Courgnaud V, Laure F, Brassard A, et al. Frequent and early in utero HIV-1 infection. AIDS Res Hum Retroviruses. 1991;7:337-341.
2. Rouzioux C, Costagliola D, Burgard M, et al. Timing of mottier-to-child HIV-1 transmission depends on maternal status: the HIV Infection in Newborns French Collaborative Study Group. AIDS. 1993;S49-S52.
3. Goedert JJ, Duliege AM, Amos CI, Felton S, Biggar RJ. High risk of HIV-1 infection for first-born twins: the International Registry of HIV-Exposed Twins. Lancet. 1991;338:1471-1475.
4. Burgard M, Mayaux MJ, Blanche S, et al. The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates: the HIV Infection in Newborns French Collaborative Study Group. N Engl J Med. 1992:327:1192-1197.
5. Van de Perre P, Simonon A, Msellati P, et al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant: a prospective cohort study in Kigali, Rwanda. N Engl J Med. 1991;325:593-598.
6. Datta P, Embree JE, Kreiss JK, et al. Motherto-child transmission of human immunodeficiency virus type 1: report from the Nairobi Study. J Infect Dis. 1994;170:1134-1140.
7. Ryder RW, Nsa W, Hassig SE, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med. 1989;320:1637-1642.
8. Mofenson L. Epidemiology and determinants of vertical HIV transmission. Semin Pediatr Infect Dis. 1994;5:252-265.
9. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1: European Collaborative Study. Lancet. 1992;339:1007-1012.
10. Boyer PJ, Dillon M, Navaie M, et al. Factors predictive of maternal-fetal transmission of HIV-1: preliminary analysis of zido vudine given during pregnancy and/or delivery. JAMA. 1994;271:1925-1930.
11. Borkowsky W, Krasinski K, Cao Y, et al. Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes. J Pediatr 1994;125:345-351.
12. Roques P, Maree D, Courpotin C, et al. Correlation between HIV pro virus burden and in utero transmission. AIDS. 1993;7(suppl 2):S39-S43.
13. Weiser B, Nachman S, Tropper P, et al. Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load. Proc Natl Acad Sci USA. 1994;91:8031-8041.
14. Landesman SH, Burns D, Kalish L, et al. Increased duration of rupture of membranes (ROM) is associated with an increased risk of perinatal HIV-1 transmission. In: Program and abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy; October 4-7, 1994; Orlando, Fla. Abstract 119.
15. Bryson YJ, Luzuriaga K, Sullivan JL, Wara DW. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med. 1992;327:1246-1247.
16. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180.
17. Miles SA, Balden E, Magpantay L, et al. Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates: Southern California Pediatric AIDS Consortium. N Engl J Med. 1993;328:297-302.
18. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990;28:495-503.
19. Dickover RE, Dillon M, Gillette S, et al. Rapid increases in HIV-1 load correlate with early disease progression and loss of CD4 cells in vertically infected infants. J Infect Dis 1994;170:1279-1284.
20. Schnittman SM, Psallidopoulos MC, Lane HC, et al. The reservoir for HIV-I in human peripheral blood is a T cell that maintains expression of CD4. Science. 1989;245:305-308.
21. AIDS Clinical Trials Group Virology Technology Advisory Committee. ACTG Virology Manual for HIV Laboratories. Bethesda, Md: Division of AIDS, National Institute of Allergy and Infectious Disease, National Institutes of Health; 1994.
22. Hausner MA, Giorgi JV, Plaeger-Marshall S.A reproducible method to detect CD8 T cell mediated inhibition of HIV production from naturally infected CD4 cells. J Immunol Methods. 1993;157:181-187.
23. Zweig MH, Campbbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39:561-577.
24. Centers for Disease Control and Prevention. 1993 Revised HIV classification system for adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41:1-18.
25. Jackson JB, Kataaha P, Horn DL, et al. Beta 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women. AIDS. 1993;7:1475-1479.
26. Scarlatti G, Leittier T, Hodara V, et al. Neutralizing antibodies and viral characteristics in motherto-child transmission of HIV-1. AIDS. 1993;S45-S48.
27. Kliks SC, Wara DW, Landers DV, Levy JA. Features of HIV-1 that could influence maternal-child transmission. JAMA 1994;272:467-474.
28. Frenkel LM, Wagner LEn, Demeter LM, et al. Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1. Clin Infect Dis. 1995;20: 1321-1326.
29. Fang G, Burger H, Grimson R, et al. Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother to child transmission. Proc Natl Acad Sci USA. 1995;92:12100-12104.